...
The results for this analysis could be represented in tabular format as shown in the following table, where the groupingId and groupId values from the 2 two instances of the ResultGroup class found in the resultGroups attribute for each each result are represented in separate pairs of columns ("resultGroup1_groupingIdrgroupingId1"/"resultGroup1_groupIdgroupId1" and "resultGroup2_groupingIdgroupingId2"/"resultGroup2_groupIdgroupId2") so that each result is represented on a single row:
Dataset2 |
---|
operationId | resultGroup1_groupingId | resultGroup1_groupId | resultGroup2_groupingId | groupingId1 | groupId1 | groupingId2 | groupId2resultGroup2_groupId | rawValue | formattedValue |
---|
Mth01_CatVar_Summ_ByGrp_1_n | AnlsGrouping_01_Trt | AnlsGrouping_01_Trt_1 | AnlsGrouping_02_Sex | AnlsGrouping_02_Sex_1 | 33 | 33 | Mth01_CatVar_Summ_ByGrp_1_n | AnlsGrouping_01_Trt | AnlsGrouping_01_Trt_1 | AnlsGrouping_02_Sex | AnlsGrouping_02_Sex_2 | 53 | 53 | Mth01_CatVar_Summ_ByGrp_1_n | AnlsGrouping_01_Trt | AnlsGrouping_01_Trt_2 | AnlsGrouping_02_Sex | AnlsGrouping_02_Sex_1 | 34 | 34 | Mth01_CatVar_Summ_ByGrp_1_n | AnlsGrouping_01_Trt | AnlsGrouping_01_Trt_2 | AnlsGrouping_02_Sex | AnlsGrouping_02_Sex_2 | 50 | 50 | Mth01_CatVar_Summ_ByGrp_1_n | AnlsGrouping_01_Trt | AnlsGrouping_01_Trt_3 | AnlsGrouping_02_Sex | AnlsGrouping_02_Sex_1 | 44 | 44 | Mth01_CatVar_Summ_ByGrp_1_n | AnlsGrouping_01_Trt | AnlsGrouping_01_Trt_3 | AnlsGrouping_02_Sex | AnlsGrouping_02_Sex_2 | 40 | 40 | Mth01_CatVar_Summ_ByGrp_2_pct | AnlsGrouping_01_Trt | AnlsGrouping_01_Trt_1 | AnlsGrouping_02_Sex | AnlsGrouping_02_Sex_1 | 38.3720930232558 | ( 38.4) | Mth01_CatVar_Summ_ByGrp_2_pct | AnlsGrouping_01_Trt | AnlsGrouping_01_Trt_1 | AnlsGrouping_02_Sex | AnlsGrouping_02_Sex_2 | 61.6279069767442 | ( 61.6) | Mth01_CatVar_Summ_ByGrp_2_pct | AnlsGrouping_01_Trt | AnlsGrouping_01_Trt_2 | AnlsGrouping_02_Sex | AnlsGrouping_02_Sex_1 | 40.4761904761905 | ( 40.5) | Mth01_CatVar_Summ_ByGrp_2_pct | AnlsGrouping_01_Trt | AnlsGrouping_01_Trt_2 | AnlsGrouping_02_Sex | AnlsGrouping_02_Sex_2 | 59.5238095238095 | ( 59.5) | Mth01_CatVar_Summ_ByGrp_2_pct | AnlsGrouping_01_Trt | AnlsGrouping_01_Trt_3 | AnlsGrouping_02_Sex | AnlsGrouping_02_Sex_1 | 52.3809523809524 | ( 52.4) | Mth01_CatVar_Summ_ByGrp_2_pct | AnlsGrouping_01_Trt | AnlsGrouping_01_Trt_3 | AnlsGrouping_02_Sex | AnlsGrouping_02_Sex_2 | 47.6190476190476 | ( 47.6) |
|
...
Dataset2 |
---|
operationId | operation_labelresultGroup1_groupingId | groupingId1 | resultGroup1_grouping_labellabel1resultGroup1_groupId | groupId1 | resultGroup1_group_labellabel1resultGroup2 | _groupingIdgroupingId2 | resultGroup2_grouping_labellabel2resultGroup2_groupId | groupId2 | resultGroup2_group_labellabel2 | rawValue | formattedValue |
---|
Mth01_CatVar_Summ_ByGrp_1_n | n | AnlsGrouping_01_Trt | Treatment | AnlsGrouping_01_Trt_1 | Placebo | AnlsGrouping_02_Sex | Sex | AnlsGrouping_02_Sex_1 | Male | 33 | 33 | Mth01_CatVar_Summ_ByGrp_1_n | n | AnlsGrouping_01_Trt | Treatment | AnlsGrouping_01_Trt_1 | Placebo | AnlsGrouping_02_Sex | Sex | AnlsGrouping_02_Sex_2 | Female | 53 | 53 | Mth01_CatVar_Summ_ByGrp_1_n | n | AnlsGrouping_01_Trt | Treatment | AnlsGrouping_01_Trt_2 | Xanomeline Low Dose | AnlsGrouping_02_Sex | Sex | AnlsGrouping_02_Sex_1 | Male | 34 | 34 | Mth01_CatVar_Summ_ByGrp_1_n | n | AnlsGrouping_01_Trt | Treatment | AnlsGrouping_01_Trt_2 | Xanomeline Low Dose | AnlsGrouping_02_Sex | Sex | AnlsGrouping_02_Sex_2 | Female | 50 | 50 | Mth01_CatVar_Summ_ByGrp_1_n | n | AnlsGrouping_01_Trt | Treatment | AnlsGrouping_01_Trt_3 | Xanomeline High Dose | AnlsGrouping_02_Sex | Sex | AnlsGrouping_02_Sex_1 | Male | 44 | 44 | Mth01_CatVar_Summ_ByGrp_1_n | n | AnlsGrouping_01_Trt | Treatment | AnlsGrouping_01_Trt_3 | Xanomeline High Dose | AnlsGrouping_02_Sex | Sex | AnlsGrouping_02_Sex_2 | Female | 40 | 40 | Mth01_CatVar_Summ_ByGrp_2_pct | % | AnlsGrouping_01_Trt | Treatment | AnlsGrouping_01_Trt_1 | Placebo | AnlsGrouping_02_Sex | Sex | AnlsGrouping_02_Sex_1 | Male | 38.3720930232558 | ( 38.4) | Mth01_CatVar_Summ_ByGrp_2_pct | % | AnlsGrouping_01_Trt | Treatment | AnlsGrouping_01_Trt_1 | Placebo | AnlsGrouping_02_Sex | Sex | AnlsGrouping_02_Sex_2 | Female | 61.6279069767442 | ( 61.6) | Mth01_CatVar_Summ_ByGrp_2_pct | % | AnlsGrouping_01_Trt | Treatment | AnlsGrouping_01_Trt_2 | Xanomeline Low Dose | AnlsGrouping_02_Sex | Sex | AnlsGrouping_02_Sex_1 | Male | 40.4761904761905 | ( 40.5) | Mth01_CatVar_Summ_ByGrp_2_pct | % | AnlsGrouping_01_Trt | Treatment | AnlsGrouping_01_Trt_2 | Xanomeline Low Dose | AnlsGrouping_02_Sex | Sex | AnlsGrouping_02_Sex_2 | Female | 59.5238095238095 | ( 59.5) | Mth01_CatVar_Summ_ByGrp_2_pct | % | AnlsGrouping_01_Trt | Treatment | AnlsGrouping_01_Trt_3 | Xanomeline High Dose | AnlsGrouping_02_Sex | Sex | AnlsGrouping_02_Sex_1 | Male | 52.3809523809524 | ( 52.4) | Mth01_CatVar_Summ_ByGrp_2_pct | % | AnlsGrouping_01_Trt | Treatment | AnlsGrouping_01_Trt_3 | Xanomeline High Dose | AnlsGrouping_02_Sex | Sex | AnlsGrouping_02_Sex_2 | Female | 47.6190476190476 | ( 47.6) |
|